CenterBook Partners LP Reduces Holdings in Xylem Inc. $XYL

CenterBook Partners LP trimmed its stake in shares of Xylem Inc. (NYSE:XYLFree Report) by 24.8% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 17,299 shares of the industrial products company’s stock after selling 5,703 shares during the quarter. CenterBook Partners LP’s holdings in Xylem were worth $2,552,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also bought and sold shares of the stock. AQR Capital Management LLC grew its holdings in shares of Xylem by 14.4% in the first quarter. AQR Capital Management LLC now owns 30,955 shares of the industrial products company’s stock worth $3,645,000 after purchasing an additional 3,900 shares during the last quarter. NewEdge Advisors LLC grew its holdings in Xylem by 3.3% in the 1st quarter. NewEdge Advisors LLC now owns 4,151 shares of the industrial products company’s stock worth $496,000 after acquiring an additional 132 shares during the last quarter. Empowered Funds LLC increased its position in shares of Xylem by 56.1% in the first quarter. Empowered Funds LLC now owns 8,678 shares of the industrial products company’s stock valued at $1,037,000 after acquiring an additional 3,120 shares during the period. Chicago Partners Investment Group LLC purchased a new position in shares of Xylem in the second quarter valued at about $217,000. Finally, Cullen Frost Bankers Inc. raised its stake in shares of Xylem by 70.2% during the second quarter. Cullen Frost Bankers Inc. now owns 3,766 shares of the industrial products company’s stock valued at $487,000 after acquiring an additional 1,553 shares during the last quarter. 87.96% of the stock is owned by hedge funds and other institutional investors.

Xylem Price Performance

XYL opened at $129.15 on Friday. The company has a current ratio of 1.62, a quick ratio of 1.28 and a debt-to-equity ratio of 0.12. The company has a market cap of $31.44 billion, a price-to-earnings ratio of 32.95, a price-to-earnings-growth ratio of 1.85 and a beta of 1.17. The stock has a fifty day simple moving average of $137.70 and a two-hundred day simple moving average of $141.73. Xylem Inc. has a 12-month low of $100.47 and a 12-month high of $154.27.

Xylem (NYSE:XYLGet Free Report) last released its earnings results on Tuesday, February 10th. The industrial products company reported $1.42 earnings per share for the quarter, hitting analysts’ consensus estimates of $1.42. The firm had revenue of $2.40 billion for the quarter, compared to the consensus estimate of $2.37 billion. Xylem had a net margin of 10.59% and a return on equity of 11.11%. The company’s revenue was up 6.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.18 EPS. Xylem has set its FY 2026 guidance at 5.350-5.560 EPS. Research analysts predict that Xylem Inc. will post 4.65 earnings per share for the current fiscal year.

Xylem Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 24th. Shareholders of record on Tuesday, February 24th will be paid a dividend of $0.43 per share. This is a positive change from Xylem’s previous quarterly dividend of $0.40. This represents a $1.72 dividend on an annualized basis and a dividend yield of 1.3%. The ex-dividend date of this dividend is Tuesday, February 24th. Xylem’s payout ratio is 40.82%.

Analysts Set New Price Targets

Several research firms recently issued reports on XYL. Oppenheimer set a $165.00 target price on Xylem in a research note on Thursday, February 12th. Zacks Research lowered Xylem from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 18th. Argus set a $170.00 target price on Xylem in a report on Wednesday, October 29th. Barclays cut their price target on shares of Xylem from $166.00 to $156.00 and set an “overweight” rating on the stock in a report on Wednesday, February 11th. Finally, William Blair began coverage on shares of Xylem in a report on Monday, January 26th. They issued an “outperform” rating for the company. Nine investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $158.08.

Check Out Our Latest Stock Report on Xylem

Xylem Profile

(Free Report)

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.

Featured Articles

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYLFree Report).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.